{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:59:29Z","timestamp":1787806769159,"version":"build-2784847793"},"reference-count":15,"publisher":"Centers for Disease Control and Prevention - Preventing Chronic Disease","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prev. Chronic Dis."],"DOI":"10.5888\/pcd19.220129","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T13:28:49Z","timestamp":1670419729000},"source":"Crossref","is-referenced-by-count":11,"title":["Implementation and Evaluation of a Collaborative, Pharmacy-Based Hepatitis C and HIV Screening Program"],"prefix":"10.5888","volume":"19","author":[{"given":"Donald G.","family":"Klepser","sequence":"first","affiliation":[{"name":"College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Klepser","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Ferris State University, Kalamazoo, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Peters","sequence":"additional","affiliation":[{"name":"Division of HIV\/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen W.","family":"Hoover","sequence":"additional","affiliation":[{"name":"Division of HIV\/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Weidle","sequence":"additional","affiliation":[{"name":"Division of HIV\/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54162","published-online":{"date-parts":[[2022,12,8]]},"reference":[{"key":"key-10.5888\/pcd19.220129-202211290738-R1","unstructured":"National Center for HIV, Viral Hepatitis, STD, and TB Prevention. NCHHSTP AtlasPlus. Page last reviewed October 1, 2021. Accessed December 18, 2019. https:\/\/www.cdc.gov\/nchhstp\/atlas\/index.htm"},{"key":"key-10.5888\/pcd19.220129-202211290738-R2","unstructured":"The White House. National HIV\/AIDS strategy for the United States: updated to 2020. Federal action plan. Published December 2015. Accessed December 18, 2019. https:\/\/www.hiv.gov\/sites\/default\/files\/nhas-2020-action-plan.pdf"},{"key":"key-10.5888\/pcd19.220129-202211290738-R3","unstructured":"US Department of Health and Human Services. National viral hepatitis action plan 2017\u20132020. Published January 2017. Accessed December 18, 2019. https:\/\/www.hhs.gov\/sites\/default\/files\/National%20Viral%20Hepatitis%20Action%20Plan%202017-2020.pdf"},{"key":"key-10.5888\/pcd19.220129-202211290738-R4","unstructured":"Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data \u2014 United States and 6 dependent areas, 2018. HIV Surveillance Supplemental Report 2020;25(2). Accessed December 18, 2019. https:\/\/www.cdc.gov\/hiv\/pdf\/library\/reports\/surveillance\/cdc-hiv-surveillance-supplemental-report-vol-25-2.pdf"},{"issue":"3","key":"key-10.5888\/pcd19.220129-202211290738-R5","doi-asserted-by":"publisher","DOI":"10.24926\/iip.v6i3.392","article-title":"Exploring accessibility of community pharmacy services.","volume":"6","author":"Kelling","year":"2015","journal-title":"Innov Pharm"},{"issue":"5","key":"key-10.5888\/pcd19.220129-202211290738-R6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1331\/JAPhA.2014.14045","article-title":"HIV testing in community pharmacies and retail clinics: a model to expand access to screening for HIV infection.","volume":"54","author":"Weidle","year":"2014","journal-title":"J Am Pharm Assoc (Wash DC)"},{"issue":"1","key":"key-10.5888\/pcd19.220129-202211290738-R7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1331\/JAPhA.2015.14070","article-title":"Pharmacist-provided rapid HIV testing in two community pharmacies.","volume":"55","author":"Darin","year":"2015","journal-title":"J Am Pharm Assoc (Wash DC)"},{"issue":"2","key":"key-10.5888\/pcd19.220129-202211290738-R8","first-page":"98","article-title":"Hepatitis C point-of-care screening in retail pharmacies in the United States.","volume":"13","author":"Kugelmas","year":"2017","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"key-10.5888\/pcd19.220129-202211290738-R9","doi-asserted-by":"publisher","first-page":"S259","DOI":"10.1016\/j.japh.2017.03.006","article-title":"Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center.","volume":"57","author":"Isho","year":"2017","journal-title":"J Am Pharm Assoc (Wash DC)"},{"issue":"2","key":"key-10.5888\/pcd19.220129-202211290738-R10","doi-asserted-by":"publisher","first-page":"34S","DOI":"10.1177\/0033354918801026","article-title":"The \u201cno wrong door\u201d approach to HIV testing: results from a statewide retail pharmacy-based HIV testing program in Virginia, 2014\u20132016.","volume":"133","author":"Collins","year":"2018","journal-title":"Public Health Rep"},{"issue":"4","key":"key-10.5888\/pcd19.220129-202211290738-R11","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.japh.2017.04.463","article-title":"Pharmacists performing hepatitis C antibody point-of-care screening in a community pharmacy: a pilot project.","volume":"57","author":"Dong","year":"2017","journal-title":"J Am Pharm Assoc (Wash DC)"},{"issue":"3","key":"key-10.5888\/pcd19.220129-202211290738-R12","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.30297","article-title":"Estimating prevalence of hepatitis C virus infection in the United States, 2013\u20132016.","volume":"69","author":"Hofmeister","year":"2019","journal-title":"Hepatology"},{"issue":"2","key":"key-10.5888\/pcd19.220129-202211290738-R13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.24926\/iip.v5i2.341","article-title":"Time and motion study of influenza diagnostic testing in a community pharmacy.","volume":"5","author":"Klepser","year":"2014","journal-title":"Innov Pharm"},{"issue":"3","key":"key-10.5888\/pcd19.220129-202211290738-R14","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1177\/0897190017710518","article-title":"Observation of a pharmacist-conducted group A streptococcal pharyngitis point-of-care test: a time and motion study.","volume":"31","author":"Corn","year":"2018","journal-title":"J Pharm Pract"},{"issue":"48","key":"key-10.5888\/pcd19.220129-202211290738-R15","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.15585\/mmwr.mm6848e1","article-title":"Vital signs: status of human immunodeficiency virus testing, viral suppression, and HIV preexposure prophylaxis \u2014 United States, 2013\u20132018.","volume":"68","author":"Harris","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Preventing Chronic Disease"],"original-title":[],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T13:29:21Z","timestamp":1670419761000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/pcd\/issues\/2022\/22_0129.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,8]]},"references-count":15,"URL":"https:\/\/doi.org\/10.5888\/pcd19.220129","relation":{},"ISSN":["1545-1151"],"issn-type":[{"value":"1545-1151","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,8]]},"article-number":"220129"}}